Compound Radar

Omnicell, Inc. (OMCL) Stock Analysis

Price $33.88
Market cap $1.54B
Next earnings Oct 29, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

63
63/100 Good Quality
  • Financial Health 70
  • Profitability 65
  • Business Quality 60
  • Balance Sheet 65
  • Cash Flow 45

Why this rating?

Health 63/100 — Good Quality

Strongest Financial Health 70/100
Softest Cash Flow 45/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Omnicell, Inc. (OMCL) is a Health Information Services company in the Healthcare sector. Compound Radar rates Omnicell, Inc. 63/100 (Good Quality) due to solid business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 40.33
  • Forward P/E 16.21
  • EV/Revenue 1.18

Profitability

  • Revenue Growth 7.5%
  • Gross Margin 44.0%
  • Operating Margin 5.9%
  • Net Margin 3.1%
  • ROE 3.1%

Financial strength

  • Cash $292.16M
  • Debt $200.00M
  • Net Cash $92.17M
  • Free Cash Flow $69.37M
  • Current Ratio 1.64

Similar companies

Peers in Health Information Services, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Health Information Services →

FAQ

How Compound Radar scores and tracks Omnicell, Inc. (OMCL).

View Methodology & FAQ →